Entera Bio Ltd (STU:5DT)
€ 1.6 -0.01 (-0.62%) Market Cap: 57.88 Mil Enterprise Value: 49.80 Mil PE Ratio: 0 PB Ratio: 7.32 GF Score: 38/100

Q2 2021 Entera Bio Ltd Earnings Call Transcript

Aug 16, 2021 / 12:30PM GMT
Release Date Price: €4.68 (+0.43%)
Operator

Good morning, and welcome to Entera Bio's conference call to discuss the financial and operating results for the 6 months ended June 30, 2021. (Operator Instructions)

I would now like to hand the conference over to Ramesh Ratan, the U.S.-based CFO of Entera. Please go ahead.

Ramesh Ratan
Entera Bio Ltd. - U.S. CFO

Good morning, and welcome to the call. Joining me on today's call are Spiros Jamas, our CEO; Arthur Santora, our CMO; and Phillip Schwartz, our President of R&D. A press release announcing Entera's financial and operating results for the first 6 months ended June 30, 2021, was issued earlier today. For those of you who have not seen it, it's available on the Investors section of our website, www.enterabio.com. On our call this morning, we will share with you a business update and review of our financial results, which will be followed by a question-and-answer session.

Before we begin our prepared remarks, I would like to remind you that various statements we make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot